Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Nurs Res. 2009 Mar–Apr;58(2):74–85. doi: 10.1097/NNR.0b013e31818fcee1

Table 3.

Change in Activity and Eating Outcomes Imputed Data (n = 225)

Baseline 6 months Change Base to 6 Months
12 months Change Base to 12 Months
Marker Mean (SD) Mean (SD) Mean (95% CIa) pa Mean (SD) Mean (95% CIa) pa
Physical Activity
Outcomes
Moderate+ Activity (min/day) b
 Tailored (n = 115) 337.65 (675.4) 575.02 (759.3) 237.37 (411.16 to 63.57) < .001* 509.88 (749.4) 172.23 (337.93 to 6.53) < .001*
 Generic (n = 110) 238.50 (472.5) 450.90 (600.7) 212.40 (390.10 to 34.69) < .001* 280.09 (360.1) 41.59 (211.02 to − 127.83) .211
Kcal Expended/kg/day c
 Tailored (n = 115) 31.77 (12.7) 34.56 (10.6) 2.79 (5.38 to 0.21) .002* 33.55 (10.5) 1.78 (4.51 to −0.95) .029
 Generic (n = 110) 29.66 (7.9) 32.51 (9.8) 2.85 (5.49 to 0.21) .008* 28.88 (5.6) −0.78 (2.02 to − 3.57) .380
VO2max (ml/kg/min)
 Tailored (n = 89) 21.59 (7.5) 23.59 (7.0) 1.99 (2.86 to 1.13) < .001* 23.22 (7.5) 1.62 (2.53 to 0.72) < .001*
 Generic (n = 84) 21.28 (6.9) 23.53 (6.3) 2.25 (3.14 to 1.36) < .001* 23.37 (6.2) 2.09 (3.02 to 1.16) < .001*
Stretching Exercise (min/wk) b
 Tailored (n = 115) 14.22 (26.2) 34.78 (39.7) 20.56 (30.94 to 10.19) < .001* 27.00 (39.6) 12.78 (24.34 to 1.23) < .001*
 Generic (n = 110) 17.41 (44.3) 32.89 (45.3) 15.48 (26.09 to 4.87) < .001* 36.36 (50.1) 18.95 (30.77 to 7.14) < .001*
Strength Exercise (min/wk) b
 Tailored (n = 115) 8.52 (22.3) 39.19 (49.9) 30.67 (43.83 to 17.52) < .001* 26.95 (49.6) 18.43 (32.18 to 4.67) < .001*
 Generic (n = 110) 12.95 (38.0) 35.23 (58.5) 22.28 (35.73 to 8.83) < .001* 32.83 (62.8) 19.87 (33.94 to 5.81) < .001*
Sit-and-Reach (cm)
 Tailored (n = 115) 28.16 (7.9) 30.35 (6.9) 2.19 (3.46 to 0.92) < .001* 29.99 (6.3) 1.83 (3.20 to 0.46) .002*
 Generic (n = 110) 26.68 (7.6) 30.05 (7.3) 3.37 (4.67 to 2.07) < .001* 29.82 (6.6) 3.14 (4.55 to 1.74) < .001*
Timed Chairstands (sec)
 Tailored (n = 115) 18.05 (4.8) 14.63 (3.9) −3.42 (−2.62 to −4.21) < .001* 14.14 (4.0) −3.91 (−3.03 to − 4.80) < .001*
 Generic (n = 110) 17.76 (4.9) 16.15 (4.6) −1.61 (−0.80 to −2.43) < .001* 15.92 (4.6) −1.84 (−0.93 to − 2.75) < .001*
Healthy Eating Outcomes
Fruit + Veg Servings b
 Tailored (n = 115) 5.67 (3.0) 6.82 (3.3) 1.15 (1.80 to 0.49) < .001* 6.59 (3.3) 0.92 (1.60 to 0.24) .001*
 Generic (n = 110) 5.44 (2.5) 6.17 (2.7) 0.74 (1.41 to 0.06) .004* 5.34 (2.7) 0.10 (−0.60 to 0.80) .607
Whole Grain Servings b
 Tailored (n = 115) 1.34 (1.5) 1.33 (1.2) 0.0 (0.31 to −0.32) .676 1.19 (1.1) −0.15 (0.13 to −0.42) .447
 Generic (n = 110) 1.08 (1.0) 1.06 (0.9) 0.0 (0.30 to −0.33) .915 0.95 (0.9) −0.13 (0.15 to −0.41) .115
% Calories from Fat
 Tailored (n = 115) 38.11 (6.7) 35.99 (6.4) −2.13 (−0.54 to −3.71) .001* 36.60 (6.9) −1.52 (0.11 to −3.14) .026
 Generic (n = 110) 39.99 (6.8) 38.17 (7.3) −1.82 (−0.20 to −3.44) .007* 39.84 (6.9) −0.15 (1.51 to −1.81) .826
% Calories from Saturated Fat
 Tailored (n = 115) 11.28 (2.7) 10.47 (2.4) −0.81 (−0.24 to −1.37) .001* 10.52 (2.5) −0.76 (−0.18 to − 1.33) .002*
 Generic (n = 110) 11.63 (2.3) 11.27 (2.9) −0.37 (0.21 to −0.94) .124 11.76 (2.6) 0.12 (0.71 to −0.47) .617
Biomarkers Affected by Eating and Activity
Systolic Blood Pressure
 Tailored (n = 115) 128.29 (12.5) 124.16 (11.7) −4.12 (−1.49 to −6.76) < .001* 124.36 (10.7) −3.92 (−1.03 to − 6.82) .001*
 Generic (n = 110) 126.15 (15.1) 126.83 (15.1) 0.68 (3.37 to −2.01) . 541 123.93 (14.7) −2.22 (0.74 to −5.17) .072
Diastolic Blood Pressure
 Tailored (n =115) 80.36 (7.3) 77.96 (7.7) −2.40 (−0.69 to −4.09) .001* 77.19 (7.2) −3.16 (−1.38 to −4.95) < .001*
 Generic (n = 110) 78.16 (8.5) 78.54 (7.8) 0.38 (2.12 to −1.35) .596 76.32 (7.1) −1.84 (−0.01 to −3.67) .016*
% Body Fat (BIA)
 Tailored (n =115) 35.98 (6.3) 35.48 (6.0) −0.50 (0.04 to −1.05) .026 35.43 (6.2) −0.55 (0.09 to −1.19) .040
 Generic (n = 110) 35.99 (5.7) 36.34 (5.4) 0.35 (0.90 to −0.21) . 133 36.52 (5.6) 0.53 (1.18 to 0.13) .054
Body Mass Index
 Tailored (n =115) 30.69 (6.8) 30.34 (6.6) −0.35 (0.01 to −0.71) .021 30.54 (6.8) −0.15 (0.38 to −0.68) .499
 Generic (n = 110) 29.68 (6.0) 29.25 (5.9) −0.43 (−0.06 to −0.80) .006* 29.41 (5.9) −0.26 (0.28 to −0.80) .239
Total Cholesterol
 Tailored (n =115) 202.69 (34.4) 202.42 (32.4) 0.27 (−5.59 to 6.13) .911 204.50 (33.5) −1.82 (−8.73 to 5.11) .528
 Generic (n = 110) 205.73 (36.1) 203.19 (32.0) −2.54 (3.45 to −8.53) .307 203.68 (37.3) −2.05 (5.03 to −9.13) .486
Triglycerides
 Tailored (n =115) 125.53 (51.8) 127.02 (57.0) 1.49 (14.3 to −11.3) .779 126.13 (61.0) 0.60 (11.2 to −10.0) .891
 Generic (n = 110) 142.77 (72.8) 147.39 (93.1) 4.62 (17.7 to −8.5) . 395 138.11 (65.7) −4.66 (6.2 to −15.5) .301
HDL Cholesterol
 Tailored (n =115) 61.03 (15.0) 62.16 (15.5) 1.13 (3.2 to −1.0) .196 61.96 (14.0) 0.93 (3.4 to −1.5) .358
 Generic (n = 110) 60.81 (14.2) 61.02 (15.3) 0.21 (2.4 to −2.0) .818 61.51 (14.7) 0.70 (3.2 to −1.8) .498
LDL Cholesterol
 Tailored (n =115) 120.60 (32.6) 111.62 (31.9) −8.98(−3.0 to −15.0) <.001* 107.48 (31.5) −13.12 (−6.2 to − 20.1) < .001*
 Generic (n = 110) 125.10 (36.4) 111.47 (34.8) −13.6 (−7.5 to −19.8) <.001* 105.74 (38.2) −19.36 (−12.3 to − 26.5) < .001*
a

Notes. CIs use Bonferroni adjustment for three comparisons; p values are unadjusted and are significant if < .017 (.05/3).

b

Raw values shown for interpretability; reported probabilities based on analyses of square root transformed values.

c

Raw values shown for interpretability; reported probabilities based on analyses of log transformed values.

*

Significant change p < .017